Phase Ib Investigator-Initiated Trial of Heat Shock Protein 90 Inhibitor TAS-116 (Pimitespib) Combined with Cyclin Dependent Kinase 4/6 Inhibitor Palbociclib in Advanced Breast Cancer Progressing on Palbociclib and Treatment-Refractory Solid Tumors with Retinoblastoma (Rb) Deficiency
